Clinical Scorecard: Implementation and Preparation for JACIE Accreditation in Stem Cell Transplant Programs

At a Glance

Key Highlights

• JACIE accreditation facilitates identification and resolution of clinical practice issues and enhances health worker safety.
• Root cause analysis of adverse events and infections led to targeted training and infection control measures.
• Preparation for JACIE accreditation requires significant time, resources, multidisciplinary collaboration, and motivated personnel.

Guideline-Based Recommendations

Diagnosis

• Perform root cause analysis for adverse events related to stem cell products.
• Conduct surveillance cultures (e.g., nasal swabs) of healthcare workers to identify potential pathogen carriers.

Management

• Implement targeted training sessions for clinical and laboratory staff based on identified gaps.
• Enforce strict hand hygiene and use of disposable protective equipment to reduce infection transmission.
• Consider job reassignment for colonized healthcare workers with immunological disorders to prevent patient contamination.

Monitoring & Follow-up

• Quarterly analysis of clinical data including infection rates and adverse events.
• Continuous evaluation of compliance with JACIE standards and corrective action implementation.

Risks

• Risk of product contamination due to lack of specific training in cryopreservation procedures.
• Transmission of multidrug-resistant organisms from colonized healthcare workers to immunocompromised patients.
• Immunosuppressed healthcare workers colonized with resistant bacteria pose infection risks.

Patient & Prescribing Data

Patients undergoing autologous and allogeneic hematopoietic stem cell transplantation

Quality management and accreditation processes indirectly improve patient safety by reducing adverse events and infection risks through enhanced clinical practice and staff training.

Clinical Best Practices

• Establish a multidisciplinary JACIE working group to coordinate accreditation efforts.
• Provide continuous education and training on quality standards and infection control.
• Perform regular audits and root cause analyses to identify and address clinical and procedural deficiencies.
• Engage all stakeholders including clinical staff, laboratory personnel, and management in quality improvement initiatives.

References

• European Society for Blood and Marrow Transplantation Annual Meeting 2020